We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
GIM
476
Greylin Investment Management
Virginia
$20.9M -$3.7M -36,607 -15%
CWA
477
Constellation Wealth Advisors
New York
$20.9M +$1.22M +12,034 +6%
Kayne Anderson Rudnick Investment Management
478
Kayne Anderson Rudnick Investment Management
California
$20.9M +$200K +1,982 +1%
CAM
479
Centre Asset Management
New York
$20.8M -$670K -6,630 -3%
CNAM
480
Campbell Newman Asset Management
Wisconsin
$20.8M +$739K +7,309 +4%
BSA
481
Braun Stacey Associates
New York
$20.8M -$330K -3,265 -2%
FNB
482
First Niagara Bank
New York
$20.8M -$942K -9,322 -4%
JAFL
483
Jay A. Fishman Ltd
Michigan
$20.8M -$152K -1,500 -0.8%
WA
484
Wasatch Advisors
Utah
$20.7M -$4.4M -43,503 -18%
KIA
485
KCM Investment Advisors
California
$20.7M +$622K +6,154 +3%
AMI
486
Amica Mutual Insurance
Rhode Island
$20.6M -$3.18M -31,507 -14%
MWR
487
McAdams Wright Ragen
Washington
$20.5M +$3.09M +30,604 +18%
BF
488
BOK Financial
Oklahoma
$20.5M +$1.23M +12,128 +7%
SGAM
489
Smith Group Asset Management
Texas
$20.5M -$519K -5,134 -3%
Cambridge Investment Research Advisors
490
Cambridge Investment Research Advisors
Iowa
$20.5M +$1.12M +11,065 +6%
NB
491
NBT Bank
New York
$20.3M -$1.69M -16,754 -8%
PP
492
Palladium Partners
Virginia
$20.3M -$5.34M -52,877 -21%
HCM
493
Howland Capital Management
Massachusetts
$20.3M +$701K +6,933 +4%
ABC
494
Associated Banc-Corp
Wisconsin
$20.2M +$373K +3,687 +2%
BA
495
Boston Advisors
Massachusetts
$20.2M -$3.44M -34,034 -15%
CFB
496
Cullen/Frost Bankers
Texas
$20M +$17.4K +172 +0.1%
FBNAT
497
FirstMerit Bank N.A. Trustee
Ohio
$20M +$1.39M +13,800 +8%
SIM
498
Sentry Investment Management
Wisconsin
$19.9M +$855K +8,460 +5%
PL
499
Perpetual Ltd
Australia
$19.9M +$210K +2,078 +1%
MIM
500
Martin Investment Management
Florida
$19.8M +$19.4K +192 +0.1%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.